Learn more

TIANJIN HENGJIA BIOTECHNOLOGY DEV CO LTD

Overview
  • Total Patents
    32
  • GoodIP Patent Rank
    49,172
About

TIANJIN HENGJIA BIOTECHNOLOGY DEV CO LTD has a total of 32 patent applications. Its first patent ever was published in 2018. It filed its patents most often in China. Its main competitors in its focus markets pharmaceuticals and biotechnology are Immune Ventures LLC, SEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST and PRECIGEN INC.

Patent filings in countries

World map showing TIANJIN HENGJIA BIOTECHNOLOGY DEV CO LTDs patent filings in countries
# Country Total Patents
#1 China 32

Patent filings per year

Chart showing TIANJIN HENGJIA BIOTECHNOLOGY DEV CO LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Huo Chong 27
#2 Liu Yuqiang 19
#3 Zou Qingwei 13
#4 Deng Ligang 13
#5 Du Xueming 12
#6 Li Feng'E 11
#7 Wang Yaling 11
#8 Li Xiaodan 9
#9 Sun Xudong 4
#10 Du Faming 1

Latest patents

Publication Filing date Title
CN112142837A New antigenic peptide composition and application thereof in tumor immunotherapy drugs
CN111777677A EGFR T790M new antigen epitope peptide and application thereof in treating tumors
CN111777678A EGFR L858R new antigen epitope peptide and application thereof in treating tumors
CN110172091A A kind of specific t-cell receptor and its application for EGFR L858R gene mutation
CN110128528A A kind of specific t-cell receptor and its application for EGFR L858R gene mutation
CN111848781A Specific T cell receptor aiming at EGFR L858R gene mutation and application thereof
CN111848782A Specific T cell receptor aiming at EGFR L858R gene mutation and application thereof
CN111748026A Specific T cell receptor aiming at EGFR L858R gene mutation and application thereof
CN111748029A Specific T cell receptor aiming at EGFR L858R gene mutation and application thereof
CN111748028A Specific T cell receptor aiming at EGFR L858R gene mutation and application thereof
CN111748027A Specific T cell receptor aiming at EGFR L858R gene mutation and application thereof
CN111116732A Specific TCR aiming at EGFR L858R gene mutation and application thereof
CN111116754A Specific TCR aiming at EGFR L858R gene mutation and application thereof
CN108440651A A kind of Antigenic Peptide chain group for treating tumour and its application in drug
CN108484732A A kind of Antigenic Peptide chain group for treating tumour and its application in drug
CN108715603A A kind of Antigenic Peptide chain group for treating tumour and its application in drug
CN108752424A A kind of Antigenic Peptide chain group for treating tumour and its application in drug
CN108440650A A kind of Antigenic Peptide chain group for treating tumour and its application in drug
CN108440649A A kind of Antigenic Peptide chain group for treating tumour and its application in drug
CN108250269A A kind of Antigenic Peptide chain group for treating tumour and its application in drug